Th2 infiltration is a better predictor of survival than tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC)

Susie Brousse, Florence Godey, Patrick Tas, Boris Campillo-Gimenez, Elodie Lafont, Amanda Poissonnier, Jean Levêque, Vincent Lavoué, Matthieu Le Gallo
doi: https://doi.org/10.1101/2023.06.02.23289891

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted June 06, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Th2 infiltration is a better predictor of survival than tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC)
Susie Brousse, Florence Godey, Patrick Tas, Boris Campillo-Gimenez, Elodie Lafont, Amanda Poissonnier, Jean Levêque, Vincent Lavoué, Matthieu Le Gallo
medRxiv 2023.06.02.23289891; doi: https://doi.org/10.1101/2023.06.02.23289891
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area